BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 872 filers reported holding BAXTER INTL INC in Q2 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,055,785 | -17.0% | 584,414 | +0.2% | 0.02% | -11.1% |
| Q2 2023 | $26,584,807 | +12.7% | 583,512 | +0.4% | 0.02% | +5.9% |
| Q1 2023 | $23,584,667 | -19.2% | 581,476 | +1.5% | 0.02% | -22.7% |
| Q4 2022 | $29,193,170 | -11.3% | 572,752 | -6.3% | 0.02% | -15.4% |
| Q3 2022 | $32,915,000 | -14.5% | 611,121 | +1.9% | 0.03% | -7.1% |
| Q2 2022 | $38,506,000 | -14.8% | 599,490 | +2.8% | 0.03% | -3.4% |
| Q1 2022 | $45,205,000 | -10.6% | 582,986 | -1.0% | 0.03% | -3.3% |
| Q4 2021 | $50,548,000 | +4.7% | 588,863 | -1.9% | 0.03% | -3.2% |
| Q3 2021 | $48,293,000 | +0.5% | 600,436 | +0.6% | 0.03% | 0.0% |
| Q2 2021 | $48,068,000 | -5.2% | 597,120 | -0.6% | 0.03% | -13.9% |
| Q1 2021 | $50,682,000 | -7.3% | 600,924 | -11.8% | 0.04% | -12.2% |
| Q4 2020 | $54,684,000 | -3.2% | 681,501 | -3.0% | 0.04% | -14.6% |
| Q3 2020 | $56,494,000 | -12.4% | 702,492 | -6.2% | 0.05% | -15.8% |
| Q2 2020 | $64,483,000 | +10.9% | 748,929 | +4.5% | 0.06% | -10.9% |
| Q1 2020 | $58,163,000 | -6.2% | 716,374 | -3.4% | 0.06% | +23.1% |
| Q4 2019 | $62,000,000 | -6.3% | 741,448 | -2.0% | 0.05% | -10.3% |
| Q3 2019 | $66,190,000 | +12.8% | 756,718 | +5.6% | 0.06% | +9.4% |
| Q2 2019 | $58,667,000 | -0.7% | 716,323 | -1.5% | 0.05% | -3.6% |
| Q1 2019 | $59,105,000 | +11.6% | 726,915 | -9.6% | 0.06% | -1.8% |
| Q4 2018 | $52,947,000 | -21.9% | 804,421 | -8.6% | 0.06% | -6.7% |
| Q3 2018 | $67,835,000 | +7.7% | 879,947 | +3.2% | 0.06% | +3.4% |
| Q2 2018 | $62,991,000 | +12.5% | 853,074 | -0.9% | 0.06% | +7.4% |
| Q1 2018 | $55,997,000 | -26.4% | 860,954 | -26.8% | 0.05% | -22.9% |
| Q4 2017 | $76,073,000 | -15.3% | 1,176,872 | -17.8% | 0.07% | -19.5% |
| Q3 2017 | $89,846,000 | +2.9% | 1,431,802 | -0.8% | 0.09% | -1.1% |
| Q2 2017 | $87,341,000 | +1.1% | 1,442,705 | -13.4% | 0.09% | -15.4% |
| Q1 2017 | $86,431,000 | +26.1% | 1,666,615 | +7.8% | 0.10% | +19.5% |
| Q4 2016 | $68,541,000 | -18.1% | 1,545,798 | -12.1% | 0.09% | -20.9% |
| Q3 2016 | $83,704,000 | +12.5% | 1,758,463 | +6.9% | 0.11% | +5.8% |
| Q2 2016 | $74,408,000 | +137.6% | 1,645,478 | +115.9% | 0.10% | +131.1% |
| Q1 2016 | $31,314,000 | +12.7% | 762,271 | +4.7% | 0.04% | +9.8% |
| Q4 2015 | $27,779,000 | +18.7% | 728,148 | +2.2% | 0.04% | +10.8% |
| Q3 2015 | $23,398,000 | -53.2% | 712,294 | -0.4% | 0.04% | -50.7% |
| Q2 2015 | $49,998,000 | +2.1% | 714,969 | +0.0% | 0.08% | +2.7% |
| Q1 2015 | $48,970,000 | -3.1% | 714,899 | +3.7% | 0.07% | -6.4% |
| Q4 2014 | $50,528,000 | +3.7% | 689,425 | +1.6% | 0.08% | -6.0% |
| Q3 2014 | $48,717,000 | +0.6% | 678,787 | +1.3% | 0.08% | +2.5% |
| Q2 2014 | $48,449,000 | -0.9% | 670,109 | +0.9% | 0.08% | -6.9% |
| Q1 2014 | $48,871,000 | +7.7% | 664,187 | +1.8% | 0.09% | +2.4% |
| Q4 2013 | $45,371,000 | +6.3% | 652,349 | +0.4% | 0.08% | -3.4% |
| Q3 2013 | $42,677,000 | -3.4% | 649,674 | +1.9% | 0.09% | -10.2% |
| Q2 2013 | $44,178,000 | – | 637,761 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |